agilon health, inc. (NYSE:AGL) Receives $6.05 Average PT from Analysts

agilon health, inc. (NYSE:AGL) has received a consensus rating of “Reduce” from the twenty brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $6.05.

A number of equities analysts recently weighed in on AGL shares. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Citigroup dropped their price target on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday, November 13th. Stifel Nicolaus dropped their price target on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a research note on Tuesday, November 19th.

agilon health Stock Performance

NYSE:AGL opened at $2.23 on Friday. The stock has a market cap of $918.80 million, a P/E ratio of -2.33 and a beta of 0.51. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock’s 50-day moving average is $2.66 and its 200-day moving average is $4.58. agilon health has a 1-year low of $1.50 and a 1-year high of $13.76.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the company earned ($0.06) earnings per share. Equities research analysts anticipate that agilon health will post -0.47 earnings per share for the current year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

A number of institutional investors have recently made changes to their positions in AGL. Virtu Financial LLC acquired a new position in shares of agilon health in the 3rd quarter valued at about $120,000. Geode Capital Management LLC increased its holdings in shares of agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after purchasing an additional 84,889 shares during the period. Barclays PLC increased its holdings in shares of agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after purchasing an additional 214,830 shares during the period. XTX Topco Ltd increased its holdings in shares of agilon health by 271.1% in the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after purchasing an additional 87,481 shares during the period. Finally, State Street Corp grew its stake in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after buying an additional 215,733 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.